Related Experiment Video

Updated: Jun 20, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

Proteinuria and clinical outcomes in hypertensive patients

Ausilia Maione1, Lieven Annemans, Giovanni Strippoli

  • 1Mario Negri Sud Consortium, Renal Research, Santa Maria Imbaro, Italy.

American Journal of Hypertension
|September 5, 2009
PubMed

Insights

Proteinuria in hypertension (HT) indicates higher renal and cardiovascular risk. Managing blood pressure (BP) and proteinuria reduces adverse outcomes, with renin system drugs showing particular benefit.

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Background:

  • Proteinuria is a key indicator of kidney and cardiovascular disease in hypertensive patients.
  • Diabetic patients with hypertension are a high-risk group for proteinuria complications.
  • Effective blood pressure control and proteinuria management are crucial for improving patient outcomes.

Purpose of the Study:

  • To review outcomes associated with proteinuria in hypertension.
  • To examine current and future therapeutic strategies for managing proteinuria in hypertensive individuals.
  • To assess the role of different antihypertensives in proteinuria reduction.

Main Methods:

  • Narrative review of existing literature.
  • Analysis of therapeutic strategies for hypertension and proteinuria.
  • Examination of drug effects on proteinuria and related outcomes.

Main Results:

  • Proteinuria independently predicts renal and cardiovascular disease in hypertensive populations.
  • Blood pressure control and proteinuria management significantly reduce adverse outcomes.
  • Antihypertensive drugs have varied effects on proteinuria; renin system inhibitors offer additional benefits beyond BP reduction.
  • Economic evaluations suggest cost-saving benefits for certain interventions.

Conclusions:

  • Proteinuria management is vital in hypertensive patients, especially those with diabetes.
  • Renin system-targeting drugs provide renoprotective and antiproteinuric effects, potentially independent of blood pressure lowering.
  • Further outcomes-based research is needed to fully establish the benefits of specific antihypertensive strategies.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...